Delivery Order SPE2DB22D1202-SPE2DB24FURV4
Award Date 2/27/24
Potential Completion Date 2/28/24
Potential Value $23K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the for-profit pharmaceutical distribution company AmerisourceBergen Corporation, to provide TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML vaccines. The $3,421.00 contract has a completion date of February 2, 2024. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 indefinite delivery contract with DLA as the primary vehicle for delivering pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $46,815.50 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccines. The contract has a completion date of March 7, 2024 and was awarded on March 6, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 awarded by...
- The U.S. Defense Logistics Agency (DLA) awarded a $37,452.40 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 25 mcg/0.5 ml vials of the TYPHIM VI vaccine. This delivery order contract has an ultimate completion date of April 15, 2024. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC) with DLA Troop Support Medical with a potential value of up to $999,999,999.00 through December...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $10,263.00 order is for the TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML vaccine, to be delivered by February 5, 2024. Amerisourcebergen Drug Corp, as the prime contractor, will provide this pharmaceutical product to support military treatment programs and facilities. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,732.82 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes, with completion scheduled for December 3, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, is fulfilling this...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML pharmaceuticals. The contract has a completion date of February 5, 2024 and a potential value of $3,586.12. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor on this delivery order, which was not set aside for any particular business type. This order is part...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $24,340.60 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the delivery of 4,559,976,564 units of the Typhim VI 25 mcg/0.5 mL vaccine vials in support of military treatment programs and facilities. This delivery order is a part of Amerisourcebergen Drug Corp's larger $999,999,999.00 indefinite...
- The Defense Logistics Agency (DLA) awarded a $7,555.37 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on January 16, 2026, with an ultimate completion date of January 20, 2026. This non-competitive delivery order was placed against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The vaccine product will be delivered to the company's corporate...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $5,617.86 contract is for the provision of 4,563,955,495 units of the vaccine TYPHIM VI 25 MCG/0.5 ML VIAL 10ML. The delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,872.64 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a pharmaceutical product, with a completion date of March 5, 2024. This delivery order is issued under a larger $999,999,999.00 indefinite delivery contract (IDC) between...